Loading
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (1 ops.)
Latest filing published 16 Oct 2026 for Moleculin Biotech, Inc..
Filing timeline
BuySaleWalter Klemp V
Closed purchases
Market purchases
8
Positive at T+90
40%
Median T+90
-2.3%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Discover the complete record of transactions filed by Walter Klemp V, Chairman & CEO. Officer active across 3 companies, notably Moleculin Biotech, Inc.. Cumulatively, 54 disclosures have been published. Breakdown: 8 buys · 1 sell. Total volume traded: €671k. History available since 11 May 2017. The latest transaction was disclosed on 15 October 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Walter Klemp V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations54 total
207,500 sharesCommon StockSEC:0001437749-26-032865:0
48,659 shares@ US$0.37010.21% mcap5.5% of flowCommon StockSEC:0001437749-26-032865:1
13,000 sharesCommon StockSEC:0001437749-26-029835:0
533,333 sharesCommon StockSEC:0001437749-26-025928:0
Canonical exit: 1 Nov 2026 (T+90)
150 sharesCommon StockSEC:0001437749-26-021611:0
37 sharesCommon StockSEC:0001437749-26-021611:1
360 sharesCommon StockSEC:0001437749-26-021611:2
88 sharesCommon StockSEC:0001437749-26-021611:3
28,750 sharesCommon StockSEC:0001437749-25-033683:0
914 shares@ US$0.267Common StockSEC:0001437749-25-021050:1
8,990 sharesCommon StockSEC:0001437749-25-021050:2
2,190 shares@ US$0.267Common StockSEC:0001437749-25-021050:3
675,675 shares@ US$0.37Common StockSEC:0001437749-25-021050:4
Canonical exit: 21 Sept 2025 (T+90)
3,750 sharesCommon StockSEC:0001437749-25-021050:0
406 shares@ US$0.6852Common StockSEC:0001437749-25-020802:1
1,667 sharesCommon StockSEC:0001437749-25-020802:0
240 shares@ US$3.57Common StockSEC:0001437749-24-022252:1
982 sharesCommon StockSEC:0001437749-24-022252:0
2,190 shares@ US$3.74Common StockSEC:0001437749-24-021197:1
8,990 sharesCommon StockSEC:0001437749-24-021197:0
914 shares@ US$3.78Common StockSEC:0001437749-24-020995:1
3,750 sharesCommon StockSEC:0001437749-24-020995:0
406 shares@ US$4.14Common StockSEC:0001437749-24-020663:1
1,667 sharesCommon StockSEC:0001437749-24-020663:0
188,404 shares@ US$0.6942.4% of flowCommon StockSEC:0001437749-23-035340:0
Canonical exit: 25 Mar 2024 (T+90)
25 of 54 declarations
About Walter Klemp V
KLEMP WALTER V is Président-Directeur Général. He is linked to Moleculin Biotech, Inc., where he is CEO and President, and to Soliton, Inc., where he is Executive Chairman. He has made 27 filings in total, and, across the recent sampled filings held, buy amounts are 278132 EUR and sell amounts are 8506957 EUR, with filings ranging from 2021-07-06 to 2026-06-24.
